Insider buying
~$12K1,000 sh @ $11.70
Traded Apr 15 · filed 2 days later
A Keros Therapeutics director paid $12K out of pocket for Keros Therapeutics shares. Shares held went up 13% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 2, 2026 · Filed Apr 6, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
option exercise
Code M — exercise or conversion of a derivative security
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded Apr 15 · filed 2 days later
A Keros Therapeutics director paid $12K out of pocket for Keros Therapeutics shares. Shares held went up 13% with this purchase.
Insider filing
Traded Apr 2 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Feb 24 · filed 31 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.